WHITNEY RANDOLPH: Open Payments
NPI 1386247740 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,452 in 28 payments from 12 companies in 2025. Trend: 2023 $728 · 2024 $1,764 · 2025 $3,452
Food & beverage: $1,749Consulting: $1,608Education: $95
| Company | Payments | Amount |
|---|---|---|
| SANOFI US SERVICES INC. | 4 | $1,849 |
| SANOFI-AVENTIS U.S. LLC | 6 | $654 |
| Incyte Corporation | 5 | $334 |
| Astellas Pharma US Inc | 3 | $163 |
| PFIZER INC. | 1 | $119 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $98 |
| Legend Biotech USA Inc. | 1 | $84 |
| Merck Sharp & Dohme LLC | 1 | $34 |
| Syndax Pharmaceuticals, Inc. | 1 | $33 |
| GlaxoSmithKline, LLC. | 1 | $32 |
Products named: REZUROCK, NIKTIMVO, Jakafi, ADCETRIS, LIVTENCITY, CARVYKTI, Cresemba, PREVYMIS.
Industry payments across TX — which companies pay providers there.
